Reporting owner · CIK 0001689575

Stueland Katherine

Visual SEC Form 4 history across 1 companies, 16 transactions and 4 filings.

CEOCHIEF EXECUTIVE OFFICERGeneDx Holdings Corp.
Open-market mix
Latest filingSep 11, 2026, 08:13 PM
Filings4Form 4 records
Buying$00 purchases
Selling$6.7M12 sales
Net value−$6.7MBuys minus sells
Companies12 securities
Most recentSep 09, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1580-8-1511Jan 251Sep 26

Net value flow

Buys minus sells

Jan 25
−$6.4M
Sep 26
−$310.9K

Transaction texture

Ownership and ticket size

Average P/S size$558.9K
Median P/S size$315.7K
Direct16
Indirect0
Sep 09, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern4Derivative Transactionfiling-context1Direct Ownershipfiling-context13Large Holdings Increaseholdings1Large Holdings Reductionholdings5Large Salesize4Repeat Sellerpattern1010b5-1 Detectedfiling-context10

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at GeneDx Holdings Corp. on Sep 09, 2026 valued at $310,932.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at GeneDx Holdings Corp. on Sep 09, 2026 valued at $310,932.

Review SEC filing

Associated companies

Visual map of known reporting history

WGSGeneDx Holdings Corp.16 transactions · latest Sep 11, 2026, 08:13 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
WGSStueland Katherine
CEO
exercise6.54k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction
0.0%09/1109/09
WGSStueland Katherine
CEO
sale3.69k-$31.0MS
Cluster Selling Direct Ownership
0.0%09/1109/09
WGSStueland Katherine
CEO
exercise6.54k$0M
Direct Ownership
0.0%09/1109/09
WGSStueland Katherine
CEO
exercise3.87k$0M
Derivative Transaction Direct Ownership
—01/31/202501/29/2025
WGSStueland Katherine
CEO
sale1.65k-$13.0MS
Direct Ownership Large Holdings Reduction Repeat Seller
—01/31/202501/29/2025
WGSStueland Katherine
CEO
exercise3.87k$0M
Direct Ownership Large Holdings Increase
—01/31/202501/29/2025
WGSStueland Katherine
CEO
sale10b5-110.0k-$96.4MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—01/10/202501/07/2025
WGSStueland Katherine
CEO
sale10b5-19.17k-$87.6MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—01/10/202501/07/2025
WGSStueland Katherine
CEO
sale10b5-18.43k-$79.6MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—01/10/202501/07/2025
WGSStueland Katherine
CEO
sale10b5-123.8k-$222MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—01/10/202501/07/2025

Stueland Katherine Insider Activity FAQ

SEC Form 4 context

Who is Stueland Katherine?

Stueland Katherine is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001689575.

Which companies has Stueland Katherine reported transactions for?

GeneDx Holdings Corp.

When was Stueland Katherine's latest insider buy?

No open-market insider purchase is available for this period.

When was Stueland Katherine's latest insider sale?

sale at GeneDx Holdings Corp. on Sep 09, 2026 valued at $310,932.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.